Robinson+Cole Represents TradeUP Acquisition Corp. in Complex DeSPAC Transaction with Estrella Biopharma, Inc.

Robinson+Cole is pleased to announce that it has represented TradeUP Acquisition Corp. (UPTD) in the closing of its business combination with Estrella Biopharma, Inc., a preclinical-stage biopharmaceutical company developing T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. The transaction, valuing the post-combination combined entity at $325 million, was announced on October 3, 2022, and was closed on September 29, 2023. The combined public company, Estrella Immunopharma, Inc. (Nasdaq: ESLA), will commence trading on the Nasdaq Capital Market on Monday, October 2, 2023.

The team advising on the transaction, led by Arila E. Zhou, included Capital Market + Securities Team members Yang Xu, Tiange (Tim) Chen, Yi (Tiffany) Liu and Samuel C. Maduabueke. The cross-disciplinary team was also supported by Business Transactions Group lawyer Kiernan L. Ignacio, Transactional Health Law Group co-chair Leslie J. Levinson, Intellectual Property + Technology Group co-chair John L. Cordani and Intellectual Property + Technology Group partner Kathleen M. Porter. Read more.

Capital Markets + Securities Team Pleased to Represent Feutune Light Acquisition Corporation in IPO

Robinson+Cole’s Capital Markets + Securities Team (the Team) represented Feutune Light Acquisition Corporation, a newly organized blank check company, in completing its initial public offering on June 21, 2022 of 9,775,00 units at an offering price of $10.00 per unit, which includes 1,225,000 units issued pursuant to the full exercise of the underwriter’s over-allotment option, for aggregate gross proceeds to the Company of $97.75M. The units began trading on the Nasdaq Global Market under the ticker symbol “FLFVU” on June 16, 2022. The Team members advising on the offering were Arila Zhou, Tim Chen, Christopher Homsy, Yang Xu and Samuel Maduabueke. Read more.

Transactional Health Law Team Represents Visiting Nurse Association and BlackTree/Simione in Recent Deals

Robinson+Cole’s Transactional Health Law Group, led by co-chair Leslie J. Levinson, represented Visiting Nurse Association (VNA), a 125-year-old nonprofit in Omaha, NE and Council Bluffs, IA in the purchase of its home health and hospice operations by Amedisys, a leading national provider of home health, hospice, and personal care. Les served as prime counsel and led the team of Michael J. Kearney, Ryan V. Leichsenring, Virginia E. McGarrity, Kathryn M. Rattigan, Conor O. Duffy, Samuel C. Maduabueke and R+C alum Adam Tamzoke. The transaction is expected to close on or around July 1, 2021. Read more in the VNA press release.

In addition, the Transactional Health Law Group represented Connecticut-based Simione Healthcare Consultants and Pennsylvania-based BlackTree Healthcare Consulting in the execution of “a strategic and equal combination” to form SimiTree Healthcare Consulting. SimiTree will help post-acute healthcare organizations achieve clinical and financial excellence through consulting, outsourcing, and talent solutions. The merger is backed by Chicago-based health care PE firm Sheridan Capital, which focuses on lower-middle market buyouts and growth equity in the U.S. and Canada. Les led the team of Adam Anderson, Shant H. Chalian, Michael Kearney, Eric M. Kogan, Virginia McGarrity, Endicott Peabody IV, Kathryn Rattigan, Frank W. Eucalitto, and Michael G. Lisitano. Read more in Home Health Care News.

Robinson+Cole Welcomes Fall Class

Robinson+Cole welcomes back the following members from our summer class and internship programs: Christopher Y. Eddy (University of North Carolina School of Law), Michael G. Lisitano (Quinnipiac University School of Law), Ryan M. Messina (Widener University School of Law), Samuel C. Maduabueke (University of Connecticut School of Law), Annecca H. Smith (Washington University in St. Louis School of Law), and Kayla N. West (Wake Forest University School of Law), and congratulates them on their recent graduation.